University of Illinois at Peoria - College of Medicine

Education
MD – The George Washington University School of Medicine, Washington, DC (1972)
Internship and Residency -- Department of Medicine, Washington Hospital Center, Washington, DC  (1972-1974)
Residency -- Department of Pediatrics, University of Vermont Medical Center, Burlington, Vermont (1974-1976)
Fellowship -- State University of New York, Upstate Medical Center, Syracuse, New York  (1976-1979)

Research Interests
Newborn megakaryocytopoiesis 
Anemia of prematurity 
Hemophilia/thrombophilia 
Hodgkin lymphoma/BMT 
Neuroblastoma associated opsoclonus-myoclonus-ataxia syndrome

Selected Publications
Cole P. Trippett T, Drachtman R, de Alarcón, P, Lu Chen, Schwartz C.  AHOD0321: A COG Phase 2 Study of Weekly Gemcitabine and Vinorelbine for Children with Recurrent or Refractory Hodgkin Disease, A Children’s Oncology Group Report.  J Clinical Oncology. 2009 Mar 20; 27 (9): 1456-61; Epub 2009 Feb 17.

Schwartz CL, Constine LC, Villaluna D., London WB, Hutchison R, Sposto R, Lipshultz S, Turner C, de Alarcón P, Chauvenet A.  A Risk-Adapted, Response-Based approach using ABVE-PC for Children and Adolescents with Intermediate and High Risk Hodgkin Lymphoma: The Results of P9425. Blood.  In Print 

Qi L, Cazares L, Johnson C, de Alarcón, P, Kupfer G, Semmes OJ. Serum Protein Expression Profiling In Pediatric Hogkin Lymphoma: A Report from the Children’s Oncology Group. Pediatric Blood and Cancer 2008 (in press).

Tebbi CK, London WB, Friedman D, Villaluna D, de Alarcón, P, Constine LS, Mendenhall, Sposto R, Chauvenet A, Schwartz C. Dexrazoxane-associated Risk for Secondary Malignancy in Pediatric Hodgkin Disease. Children’s Oncology Group. Journal of Clinical Oncology Feb 10; 25(5):493-500, 2007.

Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, Wharam MD, Falletta JM, de Alarcón, P , Chauvenet AR. A Randomized Trial Comparing Chemotherapy with Chemoradiotherapy for Children and Adolescents with Stages I, IIA, IIIA1 Hodgkin Disease. Children’s Oncology Group. J Pediatric Hematol Oncol 28(6):362-8, 2006.

Wimmer RS, Chauvenet AR, London WB, Villaluna D, de Alarcón, P, Schwartz CL. Treatment of Children with Relapsed Hodgkin Disease with APE (cytosine arabinoside (A), cis-platinum (P), and etoposide (E)) chemotherapy: A Pediatric Oncology Group Trial. Pediatr Blood Cancer 46:370-4, 2006.

Tebbi CK, Mendenhall N, London WB, Williams JL, de Alarcón, P, Chauvenet AR. Treatment of Stage I, IIA, IIIA1 Pediatric Hodgkin Disease with Doxorubicin, Bleomycin, Vincristine and Etoposide (DBVE) and Radiation: A Children’s Oncology Group Study. Pediatr Blood Cancer Feb;46(2):198-202, 2006.

Matthay KK, Blaes F, Hero B, Plantaz D, de Alarcón, P, Mitchell WG, Pike M, Pistoia V. Opsoclonus Myoclonus Syndrome in Neuroblastoma a Report from a Workshop on the Dancing Eyes Syndrome at the Advances in Neuroblastoma Meeting in Genoa, Italy, 2004. Cancer Lett Oct 18;228(1-2):275-82, 2005.

de Alarcón, P, Benjamin R, Dugdale M, Kessler C, Shopnick R, Smith P, Abshire T, Hambleton J, Matthew P, Ortiz I, Cohen A, Konkle BA, Streiff M, Lee M, Wages D, Corash L. Fresh Frozen Plasma Prepared with Amotosalen HCI (S-59) Photochemical Pathogen Inactivation: transfusion of patients with congenital coagulation factor deficiencies. Transfusion Aug;45(8):1362-72, 2005.

de Alarcón PA, Sennett MM. Successful use of Refacto continuous infusion in two paediatric patients with severe haemophilia A undergoing orthopaedic surgery. Hemophilia 10(5):655-60, 2004.

de Alarcón, P. Immune or idiopathic thrombocytopenia purpura (ITP) in childhood: What are the risks and who should be treated? J Pediatr 143(3), 2003:2870289

Johnson MC, Parkerson N, Ward S, de Alarcon PA. Pediatric sinovenous thrombosis. J Pediatr Hematol Oncol 25(4):312-315, 2003.

de Alarcón, P. The National Pediatric Blood Club Manuscripts 2001. J Pediatr Hematol Oncol 24(9):782-783, 2002.

White J, de Alarcón, P. Platelet spherocytosis: A new bleeding disorder. Am J Hematol 70:158-166, 2002.

Lipton JM, de Alarcón, P, Louis K. Diamond: an incomparable legacy. J Pediatr Hematol Oncol 23(6):371-2, 2001.

de Alarcón, P. The National Pediatric Blood Club. J Pediatr Hematol Oncol 23(3) 174:2001; with related edited manuscripts 23(3):175-178, 2001.

Amar AM, Tomlinson G, Green DM, Breslow NE, de Alarcón, P. The clinical presentation of rhabdoid tumors. J Pediatr Hematol Oncol 23(2):105-108, 2001.

de Alarcón, P. The National Pediatric Blood Club (Proceedings). J Pediatr Hematol Oncol 22(3):265;2000 with related edited manuscripts 22(3):266-293, 2000.

Goldman FD, Rumelhart SL, de Alarcón, P, Holida MD, Lee NF, Miller J, Giller R. Poor outcome in children with refractory/relapsed leukemia undergoing bone marrow transplantation with mismatched family member donors. Bone Marrow Transplant 25(9):943-948, 2000.